SCHEMBL5337798

SCHEMBL5337798

Clc1ccc(-c2nc3ncc(-c4ccsc4)cn3c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 5/20 0.45
AKT2 P31751 5/20 0.45
PTGS2 P35354 1/20 0.40
PDGFRB P09619 4/20 0.39
PDGFRA P16234 4/20 0.39
GAA P10253 3/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2A6 P11509 2/20 0.38
CYP2E1 P05181 1/20 0.38
CYP2B6 P20813 1/20 0.38
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
MAOB P27338 1/20 0.37
KDR P35968 2/20 0.36
SIRT5 Q9NXA8 1/20 0.35
CHEK2 O96017 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5348641 0.88 DPP4 (0.39) AKT1AKT2PDGFRBPDGFRAGAA
SCHEMBL5324372 0.87 AKT1 (0.55) AKT1AKT2PTGS2GAAKDM4E
SCHEMBL5321323 0.81 AKT1 (0.50) AKT1AKT2PTGS2GAAKDM4E
SCHEMBL5325683 0.79 AKT1 (0.51) AKT1AKT2PTGS2GAAKDM4E
SCHEMBL5320129 0.79 AKT1 (0.46) AKT1AKT2PTGS2GAAKDM4E
SCHEMBL5322366 0.78 AKT1 (0.50) AKT1AKT2GAAKDM4EALDH1A1
SCHEMBL5341386 0.77 AKT1 (0.49) AKT1AKT2PTGS2GAAKDM4E
SCHEMBL5343647 0.76 AKT1 (0.48) AKT1AKT2PTGS2GAAKDM4E
SCHEMBL5347663 0.76 KDM4E (0.44) AKT1AKT2PTGS2GAAKDM4E
SCHEMBL5349048 0.76 AKT1 (0.48) AKT1AKT2PTGS2GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO claimed
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO disclosed